FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights:
Net service revenues were $226.6 million for the first quarter of 2022, a 10.4% increase compared with $205.3 million for the first quarter of 2021. Net income was $8.5 million for the first quarter of 2022, compared with $8.9 million for the first quarter of 2021, while net income per diluted share was $0.53 compared with $0.55 for the same period a year ago. Adjusted EBITDA increased 16.1% to $22.4 million for the first quarter of 2022 from $19.3 million for the first quarter of 2021. Adjusted net income per diluted share was $0.77 for the first quarter of 2022 compared with $0.74 for the first quarter of 2021. Adjusted net income per diluted share for the first quarter of 2022 excludes acquisition and de novo expenses of $0.13 and stock-based compensation expense of $0.11. (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)
Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus delivered a strong financial and operating performance for the first quarter of 2022, despite some early challenges related to the surge of the Omicron variant of COVID-19. We had a significant number of caregivers in quarantine in January, which primarily affected our personal care volumes and revenues, which are reimbursed on an hourly rate basis. We were pleased, however, to see a marked decline in caregiver quarantine rates starting in February and continuing through March, resulting in personal care volumes returning to pre-Omicron levels. We are fortunate to have a team of dedicated caregivers who continue to provide outstanding care and support to our patients and their families in a safe and preferred home environment. Like most health care providers, we are facing a tight labor market, and we continue to focus on implementing effective hiring and retention strategies to attract and retain caregivers.
“Despite these challenges, we had positive trends across each of our operating segments, reflecting favorable demand for home-based care. Addus is well positioned to meet this demand, having made the critical investments necessary to provide safe and cost-effective care in the home. For the first quarter, revenues for our personal care segment, which accounted for 74.8% of total revenue, were up 0.9% on a same-store basis. This trend primarily reflects recent rate increases in Illinois that were effective November 1, 2021, offset by the Omicron-related impact on volumes in January and February. Without the impact of Omicron on volumes, our personal care segment would have been within our target range of 3-5% organic revenue growth. Our home health segment revenue more than doubled over the first quarter last year, reflecting the addition of the acquired operations of Armada Home Health and Summit Home Health that were both completed in 2021. We continued to see improvement in our hospice segment, with same store revenues up 4.4% over the prior year and sequential growth in admissions. The results for our hospice business included two months’ of contribution from the acquired operations of JourneyCare, which closed on February 1, 2022.”
Cash and Liquidity
As of March 31, 2022, the Company had cash of $124.8 million and bank debt of $259.9 million, with capacity and availability under its revolving credit facility of $377.6 million and $109.6 million, respectively. Net cash provided by operating activities was $6.0 million for the first quarter of 2022.
Allison added, “We are excited about the opportunities ahead for Addus in 2022. We have a proven operating model across the care continuum and are encouraged by the favorable demand trends for our services. Without question, the pandemic has demonstrated the value and safety of home-based care. As such, we believe we have significant prospects for continued organic growth in our current markets as well as by entering new markets through selective acquisitions. We will continue to look at opportunities in each of our operating segments with a focus on acquiring clinical services capabilities in markets where we already have strong personal care coverage, advancing our strategy to expand to more states with coverage of all three levels of home care. Under the leadership of Cliff Blessing, our new Executive Vice President and Chief Development Officer, we plan to use our financial strength to pursue our pipeline of potential acquisitions in support of our ongoing growth strategy.”
Non-GAAP Financial Measures
The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation, amortization, acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defined adjusted net income, adjusted EBITDA, adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted earnings per share to earnings per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted earnings per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.
Conference Call
Addus will host a conference call on Tuesday, May 3, 2022, at 9:00 a.m. Eastern time. To access the live call, dial (877) 270-2148 (international dial-in number is (412) 902-6510) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 10, 2022, by dialing 1-877-344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4847379.
A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.
Forward-Looking Statements
Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any future impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 25, 2022, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).
About Addus HomeCare
Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Addus HomeCare currently provides home care services to approximately 44,500 consumers through 207 locations across 22 states. For more information, please visit www.addus.com.
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||||
Condensed Consolidated Statements of Income | ||||||||
(Amounts and shares in thousands, except per share data) | ||||||||
(Unaudited) | ||||||||
Income Statement Information: | For the Three Months Ended March 31, | |||||||
2022 |
2021 |
|||||||
Net service revenues | $ |
226,634 |
|
$ |
205,302 |
|
||
Cost of service revenues |
|
156,448 |
|
|
144,105 |
|
||
Gross profit |
|
70,186 |
|
|
61,197 |
|
||
|
31.0 |
% |
|
29.8 |
% |
|||
General and administrative expenses |
|
53,152 |
|
|
45,426 |
|
||
Depreciation and amortization |
|
3,521 |
|
|
3,601 |
|
||
Total operating expenses |
|
56,673 |
|
|
49,027 |
|
||
Operating income |
|
13,513 |
|
|
12,170 |
|
||
Total interest expense, net |
|
1,762 |
|
|
1,194 |
|
||
Income before income taxes |
|
11,751 |
|
|
10,976 |
|
||
Income tax expense |
|
3,281 |
|
|
2,082 |
|
||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
Net income per diluted share: | $ |
0.53 |
|
$ |
0.55 |
|
||
Weighted average number of common shares outstanding: | ||||||||
Diluted |
|
16,079 |
|
|
16,069 |
|
||
Cash Flow Information: | For the Three Months Ended March 31, | |||||||
2022 |
2021 |
|||||||
Net cash provided by (used in) operating activities | $ |
5,983 |
|
$ |
(18,366 |
) |
||
Net cash (used in) investing activities |
|
(85,594 |
) |
|
(1,021 |
) |
||
Net cash provided by (used in) financing activities |
|
35,479 |
|
|
(144 |
) |
||
Net change in cash |
|
(44,132 |
) |
|
(19,531 |
) |
||
Cash at the beginning of the period |
|
168,895 |
|
|
145,078 |
|
||
Cash at the end of the period | $ |
124,763 |
|
$ |
125,547 |
|
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||
Condensed Consolidated Balance Sheets | ||||||
(Amounts in thousands) | ||||||
(Unaudited) | ||||||
March 31, |
||||||
2022 |
2021 |
|||||
Assets | ||||||
Current assets | ||||||
Cash | $ |
124,763 |
$ |
125,547 |
||
Accounts receivable, net |
|
136,808 |
|
138,806 |
||
Prepaid expenses and other current assets |
|
14,658 |
|
10,787 |
||
Total current assets |
|
276,229 |
|
275,140 |
||
Property and equipment, net |
|
19,073 |
|
19,322 |
||
Other assets | ||||||
Goodwill |
|
574,086 |
|
469,036 |
||
Intangible assets, net |
|
76,300 |
|
69,395 |
||
Deferred tax assets, net |
|
- |
|
6,359 |
||
Operating lease assets |
|
41,523 |
|
38,325 |
||
Total other assets |
|
691,909 |
|
583,115 |
||
Total assets | $ |
987,211 |
$ |
877,577 |
||
Liabilities and stockholders' equity | ||||||
Current liabilities | ||||||
Accounts payable | $ |
21,004 |
$ |
23,459 |
||
Accrued payroll |
|
27,720 |
|
20,255 |
||
Accrued expenses |
|
38,820 |
|
38,654 |
||
Government stimulus advance |
|
4,173 |
|
20,368 |
||
Accrued workers compensation |
|
12,640 |
|
14,380 |
||
Current portion of long-term debt |
|
- |
|
972 |
||
Total current liabilities |
|
104,357 |
|
118,088 |
||
Long-term debt, less current portion, net of debt issuance costs |
|
256,127 |
|
193,839 |
||
Long-term operating lease liabilities, less current portion |
|
39,049 |
|
35,623 |
||
Other long-term liabilities |
|
1,900 |
|
117 |
||
Total long-term liabilities |
|
297,076 |
|
229,579 |
||
Total liabilities |
|
401,433 |
|
347,667 |
||
Total stockholders' equity |
|
585,778 |
|
529,910 |
||
Total liabilities and stockholders' equity | $ |
987,211 |
$ |
877,577 |
||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||
Net Service Revenue by Segment | ||||||
(Amounts in thousands) | ||||||
(Unaudited) | ||||||
For the Three Months Ended March 31, |
||||||
2022 |
2021 |
|||||
Net Service Revenues by Segment | ||||||
Personal Care | $ |
169,632 |
$ |
164,868 |
||
Hospice |
|
47,727 |
|
36,094 |
||
Home Health |
|
9,275 |
|
4,340 |
||
Total Revenue | $ |
226,634 |
$ |
205,302 |
||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||||||
Key Statistical and Financial Data (Unautited) | ||||||||||
For the Three Months Ended March 31, |
||||||||||
2022 |
2021 |
|||||||||
Personal Care | ||||||||||
States served at period end |
|
21 |
|
|
21 |
|
||||
Locations served at period end |
|
162 |
|
|
164 |
|
||||
Average billable census total (1) |
|
36,582 |
|
|
38,327 |
|
||||
Billable hours (in thousands) |
|
7,101 |
|
|
7,567 |
|
||||
Average billable hours per census per month |
|
64.4 |
|
|
65.2 |
|
||||
Billable hours per business day |
|
110,951 |
|
|
118,237 |
|
||||
Revenues per billable hour | $ |
23.64 |
|
$ |
21.75 |
|
||||
Organic growth | ||||||||||
- Revenue (2) |
|
0.9 |
|
% |
|
2.4 |
|
% |
||
Hospice | ||||||||||
Locations served at period end |
|
33 |
|
|
34 |
|
||||
Admissions |
|
3,315 |
|
|
2,394 |
|
||||
Average daily census |
|
3,320 |
|
|
2,400 |
|
||||
Average discharge length of stay |
|
84.1 |
|
|
101.3 |
|
||||
Patient days |
|
275,488 |
|
|
216,007 |
|
||||
Revenue per patient day | $ |
173.24 |
|
$ |
167.09 |
|
||||
Organic growth | ||||||||||
- Revenue |
|
4.4 |
|
% |
|
(8.4 |
) |
% |
||
- Average daily census |
|
7.0 |
|
% |
|
(20.2 |
) |
% |
||
Home Health | ||||||||||
Locations served at period end |
|
12 |
|
|
10 |
|
||||
New Admissions |
|
3,336 |
|
|
1,168 |
|
||||
Recertifications |
|
1,316 |
|
|
657 |
|
||||
Total Volume |
|
4,652 |
|
|
1,825 |
|
||||
Visits |
|
65,213 |
|
|
27,665 |
|
||||
Organic growth | ||||||||||
- Revenue |
|
(0.5 |
) |
% |
|
0.0 |
|
% |
||
- Total admissions |
|
2.4 |
|
% |
|
14.3 |
|
% |
||
Percentage of Revenues by Payor: | ||||||||||
Personal Care | ||||||||||
State, local and other governmental programs |
|
49.5 |
|
% |
|
49.0 |
|
% |
||
Managed care organizations |
|
45.6 |
|
|
45.8 |
|
||||
Private duty |
|
2.7 |
|
|
3.0 |
|
||||
Commercial |
|
1.2 |
|
|
1.4 |
|
||||
Other |
|
1.0 |
|
% |
|
0.8 |
|
% |
||
Hospice | ||||||||||
Medicare |
|
91.1 |
|
% |
|
94.2 |
|
% |
||
Commercial |
|
4.7 |
|
|
1.5 |
|
||||
Managed care organizations |
|
3.6 |
|
|
4.1 |
|
||||
Other |
|
0.6 |
|
% |
|
0.2 |
|
% |
||
Home Health | ||||||||||
Medicare |
|
73.4 |
|
% |
|
80.7 |
|
% |
||
Managed care organizations |
|
20.5 |
|
|
18.4 |
|
||||
Other |
|
6.1 |
|
% |
|
0.9 |
|
% |
(1) The average billable census in acquisitions of 1,593 for the three ended March 31, 2021, was reclassified to average billable census - same stores for comparability purposes. Exited sites would have reduced same store census for the three months ended March 31, 2021 by 43. | ||||
(2) Management has suspended materially all of its new patient admissions under the New York consumer self-directed program and therefore excludes associated revenues from the calculation. American Rescue Plan Act of 2021 ("ARPA") funds received have also been excluded from the calculation. |
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||||
Reconciliation of Non-GAAP Financial Measures | ||||||||
(Amounts in thousands, except per share data) | ||||||||
(Unaudited) (1) | ||||||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Reconciliation of Adjusted EBITDA to Net Income: (2) | ||||||||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
Interest expense, net |
|
1,762 |
|
|
1,194 |
|
||
Income tax expense |
|
3,281 |
|
|
2,082 |
|
||
Depreciation and amortization |
|
3,521 |
|
|
3,601 |
|
||
COVID-19 expense, net |
|
- |
|
|
(591 |
) |
||
Acquisition and de novo expenses |
|
2,793 |
|
|
1,475 |
|
||
Stock-based compensation expense |
|
2,485 |
|
|
2,239 |
|
||
Restructuring and other non-recurring costs |
|
97 |
|
|
402 |
|
||
Adjusted EBITDA | $ |
22,409 |
|
$ |
19,296 |
|
||
Reconciliation of Adjusted Net Income to Net Income: (3) | ||||||||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
COVID-19 expense, net of tax |
|
- |
|
|
(479 |
) |
||
Acquisition and de novo expenses, net of tax |
|
2,013 |
|
|
1,352 |
|
||
Stock-based compensation expense, net of tax |
|
1,791 |
|
|
1,814 |
|
||
Restructuring and other non-recurring costs, net of tax |
|
70 |
|
|
326 |
|
||
Adjusted Net Income |
|
12,344 |
|
|
11,907 |
|
||
Reconciliation of Diluted Earnings per Share to Adjusted Diluted Earnings per Share: (4) | ||||||||
Diluted earnings per share | $ |
0.53 |
|
$ |
0.55 |
|
||
COVID-19 expense, net per diluted share |
|
- |
|
|
(0.03 |
) |
||
Acquisition and de novo expenses, per diluted share |
|
0.13 |
|
|
0.08 |
|
||
Stock-based compensation expense per diluted share |
|
0.11 |
|
|
0.12 |
|
||
Restructuring and other non-recurring costs per diluted share |
|
- |
|
|
0.02 |
|
||
Adjusted net income per diluted share | $ |
0.77 |
|
$ |
0.74 |
|
||
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5) | ||||||||
Net service revenues | $ |
226,634 |
|
$ |
205,302 |
|
||
Revenue associated with the closure of certain sites |
|
(0 |
) |
|
(668 |
) |
||
Adjusted net service revenues | $ |
226,634 |
|
$ |
204,634 |
|
||
(1) The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. | ||||
(2) We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(3) We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(4) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure expense and other costs, loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(5) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. |
ФРИСКО, Техас -- (BUSINESS WIRE)--Корпорация Addus HomeCare (NASDAQ: ADUS), поставщик услуг по уходу на дому, сегодня объявила о своих финансовых результатах за первый квартал, закончившийся 31 марта 2022 года.
Основные моменты первого квартала 2022 года:
Чистая выручка от услуг за первый квартал 2022 года составила 226,6 млн долларов, что на 10,4% больше по сравнению с 205,3 млн долларов за первый квартал 2021 года. Чистая прибыль составила $8,5 млн за первый квартал 2022 года по сравнению с $8,9 млн за первый квартал 2021 года, в то время как чистая прибыль на разводненную акцию составила $0,53 по сравнению с $0,55 за аналогичный период год назад. Скорректированная EBITDA увеличилась на 16,1% до 22,4 млн долларов в первом квартале 2022 года с 19,3 млн долларов в первом квартале 2021 года. Скорректированная чистая прибыль на разводненную акцию составила $0,77 за первый квартал 2022 года по сравнению с $0,74 за первый квартал 2021 года. Скорректированная чистая прибыль на разводненную акцию за первый квартал 2022 года исключает расходы на приобретение и новое строительство в размере 0,13 доллара США и расходы на компенсацию на основе акций в размере 0,11 доллара США. (Сверку всех финансовых показателей, не относящихся к GAAP и GAAP, смотрите в конце пресс-релиза.)
Комментируя результаты, Дирк Эллисон, председатель правления и главный исполнительный директор, сказал: “Addus продемонстрировал высокие финансовые и операционные показатели за первый квартал 2022 года, несмотря на некоторые ранние проблемы, связанные с резким распространением омикронного варианта COVID-19. В январе у нас было значительное количество лиц, осуществляющих уход, на карантине, что в первую очередь сказалось на объемах нашего личного ухода и доходах, которые возмещаются по почасовой ставке. Однако мы были рады увидеть заметное снижение показателей карантина для лиц, осуществляющих уход, начиная с февраля и продолжающееся до марта, в результате чего объемы личной гигиены вернулись к уровням, существовавшим до Омикрона. Нам повезло, что у нас есть команда преданных своему делу сиделок, которые продолжают оказывать выдающуюся помощь и поддержку нашим пациентам и их семьям в безопасной и комфортной домашней обстановке. Как и большинство медицинских работников, мы сталкиваемся с жестким рынком труда, и мы продолжаем фокусироваться на внедрении эффективных стратегий найма и удержания персонала для привлечения и удержания лиц, осуществляющих уход.
“Несмотря на эти проблемы, у нас были положительные тенденции в каждом из наших операционных сегментов, отражающие благоприятный спрос на уход на дому. Addus имеет хорошие возможности для удовлетворения этого спроса, сделав важные инвестиции, необходимые для обеспечения безопасного и экономически эффективного ухода на дому. За первый квартал выручка нашего сегмента средств личной гигиены, на долю которого пришлось 74,8% от общей выручки, выросла на 0,9% по сравнению с аналогичным периодом прошлого года. Эта тенденция в первую очередь отражает недавнее повышение ставок в Иллинойсе, которое вступило в силу 1 ноября 2021 года, компенсированное влиянием, связанным с Omicron, на объемы в январе и феврале. Без влияния Omicron на объемы продаж наш сегмент средств личной гигиены находился бы в пределах нашего целевого диапазона органического роста выручки на 3-5%. Выручка нашего сегмента домашнего здравоохранения более чем удвоилась по сравнению с первым кварталом прошлого года, что отражает добавление приобретенных операций Armada Home Health и Summit Home Health, которые были завершены в 2021 году. Мы продолжали наблюдать улучшение в нашем сегменте хосписов: выручка тех же магазинов выросла на 4,4% по сравнению с предыдущим годом, а количество госпитализаций последовательно росло. Результаты нашего хосписного бизнеса включали двухмесячный взнос от приобретенных операций JourneyCare, которые закрылись 1 февраля 2022 года”.
Денежные средства и ликвидность
По состоянию на 31 марта 2022 года Компания располагала денежными средствами в размере 124,8 млн долларов и банковским долгом в размере 259,9 млн долларов, при этом объем и доступность возобновляемой кредитной линии составляли 377,6 млн долларов и 109,6 млн долларов соответственно. Чистые денежные средства, полученные от операционной деятельности, составили 6,0 млн долларов США за первый квартал 2022 года.
Эллисон добавила: “Мы в восторге от возможностей, которые открываются перед Addus в 2022 году. У нас есть проверенная операционная модель во всем спектре медицинских услуг, и мы воодушевлены благоприятными тенденциями спроса на наши услуги. Без сомнения, пандемия продемонстрировала ценность и безопасность ухода на дому. Таким образом, мы считаем, что у нас есть значительные перспективы для продолжения органического роста на наших текущих рынках, а также за счет выхода на новые рынки путем выборочных приобретений. Мы продолжим изучать возможности в каждом из наших операционных сегментов, уделяя особое внимание приобретению возможностей в области клинических услуг на рынках, где у нас уже есть широкий охват услугами личной гигиены, продвигая нашу стратегию расширения на большее количество штатов с охватом всех трех уровней ухода на дому. Под руководством Клиффа Блессинга, нашего нового исполнительного вице-президента и директора по развитию, мы планируем использовать нашу финансовую мощь для продолжения процесса потенциальных приобретений в поддержку нашей текущей стратегии роста”.
Финансовые показатели, Не относящиеся к ОПБУ
Информация, представленная в этом выпуске, включает скорректированную чистую прибыль, скорректированную EBITDA и скорректированную чистую прибыль на разводненную акцию, которые являются финансовыми показателями, не относящимися к GAAP. Компания определяет скорректированную чистую прибыль как чистую прибыль до приобретения и расходов de novo, расходов на компенсацию на основе акций, расходов на реструктуризацию и прочих расходов, прибыли или убытка от продажи активов и ретроактивного повышения ставок из Иллинойса. Компания определяет скорректированный показатель EBITDA как прибыль до вычета процентных расходов, налогов, износа, амортизации, расходов на приобретение и новое строительство, расходов на компенсацию на основе акций, расходов на реструктуризацию и прочих расходов, убытков от продажи активов и ретроактивного повышения ставок из Иллинойса. Компания определяет скорректированную разводненную прибыль на акцию как прибыль на акцию, скорректированную с учетом расходов на приобретение и новое приобретение, расходов на компенсацию акций, расходов на реструктуризацию и прочих расходов, прибыли или убытка от продажи активов и ретроактивного повышения ставок из Иллинойса. Компания определила скорректированную чистую прибыль, скорректированную EBITDA, скорректированную разводненную прибыль на акцию, чтобы исключить чистые расходы на COVID, связанные с пандемией, со второго квартала 2020 года по первый квартал 2021 года. Компания определяет скорректированный чистый доход от услуг как доход, скорректированный с учетом закрытия определенных сайтов. Компания предоставила в таблицах финансовой отчетности, включенных в этот пресс-релиз, сверку скорректированной чистой прибыли с чистой прибылью, сверку скорректированной EBITDA с чистой прибылью, сверку скорректированной разводненной прибыли на акцию с прибылью на акцию и сверку скорректированных чистых доходов от услуг с чистыми доходами от услуг, в каждом случае наиболее непосредственно сопоставимый показатель GAAP. Руководство считает, что скорректированная чистая прибыль, скорректированная EBITDA, скорректированная разводненная прибыль на акцию и скорректированная чистая выручка от услуг полезны инвесторам, руководству и другим лицам при оценке операционных показателей Компании, чтобы предоставить инвесторам представление и последовательность в финансовой отчетности Компании и предоставить основу для сравнения Компаниибизнес-операций между периодами, а также для облегчения сравнения с результатами аналогичных компаний.
Конференц-связь
Addus проведет селекторное совещание во вторник, 3 мая 2022 года, в 9:00 утра по восточному времени. Чтобы получить доступ к вызову в режиме реального времени, наберите (877) 270-2148 (международный телефонный номер (412) 902-6510) и попросите присоединиться к вызову Addus HomeCare earnings. Телефонный повтор конференц-звонка будет доступен до полуночи 10 мая 2022 года, если набрать 1-877-344-7529 (международный телефонный номер (412) 317-0088) и ввести код доступа 4847379.
Прямая трансляция телефонной конференции Addus HomeCare будет доступна в разделе по связям с инвесторами на веб-сайте Компании: www.addus.com . Онлайн-трансляция также будет доступна на веб-сайте Компании в течение одного месяца, начиная примерно через два часа после завершения прямой трансляции.
Прогнозные заявления
Некоторые вопросы, обсуждаемые в этом пресс-релизе, представляют собой прогнозные заявления по смыслу Закона о реформе судебных разбирательств по частным ценным бумагам 1995 года. Такие прогнозные заявления могут быть идентифицированы такими словами, как “предварительные”, “продолжать”, “ожидать” и подобными выражениями. Эти прогнозные заявления основаны на наших текущих ожиданиях и убеждениях относительно будущих событий и их потенциального влияния на нас. Заявления прогнозного характера сопряжены с рисками и неопределенностями, которые могут вызвать фактические результаты могут существенно отличаться от выраженных или подразумеваемых в таких заявлениях прогнозного характера, включая дискреционные решения чиновников, завершения и интеграции приобретений, ожидается переход к управляемому уход, так и нашей способности успешно выполнять нашу стратегию роста, неожиданное повышение в SG&A и другие расходы, выгоды, ожидаемые и неожиданные издержки приобретения и распоряжения, планы управления, связанные с планировкой, возможность того, что ожидаемые выгоды могут не реализоваться, как предполагалось, неспособность предприятия выполнять как ожидается, изменения в возмещение расходов, изменений в постановления правительства, изменения в Addus HomeCare отношения с реферальной источников, усиление конкуренции за Addus HomeCare услуг, изменения в трактовке постановления правительства, неопределенность в отношении исхода переговоров с управляемых организаций помощи, изменение налоговых ставок, воздействие неблагоприятных погодных условиях, выше, чем предполагаемые затраты, ниже ожидаемой экономии, оценка неточности в будущих доходов, рентабельности, прибыли и роста, были ли ожидаемые поступления платежей материализуются, каких-либо будущее влияет на наш бизнес-операций, зачетов и больного населения в связи с недавним COVID-19 глобальной пандемией, и иные риски, предусмотренные в разделе факторов риска в Addus HomeCare годовой отчет по форме 10-K, поданном в комиссию по ценным бумагам и биржам 25 февраля, 2022, который доступен в www.sec.gov. Финансовая информация, описанная в настоящем документе, и периоды, к которым она относится, являются предварительными оценками, которые могут быть изменены и доработаны. Нет никакой гарантии, что окончательные суммы и корректировки не будут существенно отличаться от сумм, описанных выше, или что не будут выявлены дополнительные корректировки, влияние которых может быть существенным. Addus HomeCare не берет на себя никаких обязательств по обновлению или пересмотру каких-либо прогнозных заявлений, будь то в результате новой информации, будущих событий или иным образом. Кроме того, эти прогнозные заявления обязательно зависят от допущений, оценок и дат, которые могут быть неверными или неточными и связаны с известными и неизвестными рисками, неопределенностями и другими факторами. Соответственно, любые прогнозные заявления, включенные в настоящий пресс-релиз, не претендуют на то, чтобы быть предсказаниями будущих событий или обстоятельств, и могут не сбыться. (Далее следуют неаудированные таблицы и примечания).
Об Addus HomeCare
Addus HomeCare является поставщиком услуг по уходу на дому, которые в первую очередь включают услуги личной гигиены, которые помогают в повседневной жизни, а также хосписные и медицинские услуги на дому. Потребители Addus HomeCare - это в первую очередь лица, которые без этих услуг подвергаются риску госпитализации или помещения в специализированные учреждения, такие как пожилые люди, хронически больные и инвалиды. Клиентами-плательщиками Addus HomeCare являются федеральные, государственные и местные правительственные учреждения, организации по уходу за больными, коммерческие страховщики и частные лица. В настоящее время Addus HomeCare предоставляет услуги по уходу на дому примерно 44 500 потребителям в 207 точках в 22 штатах. Для получения дополнительной информации, пожалуйста, посетите www.addus.com .
Addus HomeCare CORPORATION AND SUBSIDIARIES | ||||||||
Condensed Consolidated Statements of Income | ||||||||
(Amounts and shares in thousands, except per share data) | ||||||||
(Unaudited) | ||||||||
Income Statement Information: | For the Three Months Ended March 31, | |||||||
2022 |
2021 |
|||||||
Net service revenues | $ |
226,634 |
|
$ |
205,302 |
|
||
Cost of service revenues |
|
156,448 |
|
|
144,105 |
|
||
Gross profit |
|
70,186 |
|
|
61,197 |
|
||
|
31.0 |
% |
|
29.8 |
% |
|||
General and administrative expenses |
|
53,152 |
|
|
45,426 |
|
||
Depreciation and amortization |
|
3,521 |
|
|
3,601 |
|
||
Total operating expenses |
|
56,673 |
|
|
49,027 |
|
||
Operating income |
|
13,513 |
|
|
12,170 |
|
||
Total interest expense, net |
|
1,762 |
|
|
1,194 |
|
||
Income before income taxes |
|
11,751 |
|
|
10,976 |
|
||
Income tax expense |
|
3,281 |
|
|
2,082 |
|
||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
Net income per diluted share: | $ |
0.53 |
|
$ |
0.55 |
|
||
Weighted average number of common shares outstanding: | ||||||||
Diluted |
|
16,079 |
|
|
16,069 |
|
||
Cash Flow Information: | For the Three Months Ended March 31, | |||||||
2022 |
2021 |
|||||||
Net cash provided by (used in) operating activities | $ |
5,983 |
|
$ |
(18,366 |
) |
||
Net cash (used in) investing activities |
|
(85,594 |
) |
|
(1,021 |
) |
||
Net cash provided by (used in) financing activities |
|
35,479 |
|
|
(144 |
) |
||
Net change in cash |
|
(44,132 |
) |
|
(19,531 |
) |
||
Cash at the beginning of the period |
|
168,895 |
|
|
145,078 |
|
||
Cash at the end of the period | $ |
124,763 |
|
$ |
125,547 |
|
Addus HomeCare CORPORATION AND SUBSIDIARIES | ||||||
Condensed Consolidated Balance Sheets | ||||||
(Amounts in thousands) | ||||||
(Unaudited) | ||||||
March 31, |
||||||
2022 |
2021 |
|||||
Assets | ||||||
Current assets | ||||||
Cash | $ |
124,763 |
$ |
125,547 |
||
Accounts receivable, net |
|
136,808 |
|
138,806 |
||
Prepaid expenses and other current assets |
|
14,658 |
|
10,787 |
||
Total current assets |
|
276,229 |
|
275,140 |
||
Property and equipment, net |
|
19,073 |
|
19,322 |
||
Other assets | ||||||
Goodwill |
|
574,086 |
|
469,036 |
||
Intangible assets, net |
|
76,300 |
|
69,395 |
||
Deferred tax assets, net |
|
- |
|
6,359 |
||
Operating lease assets |
|
41,523 |
|
38,325 |
||
Total other assets |
|
691,909 |
|
583,115 |
||
Total assets | $ |
987,211 |
$ |
877,577 |
||
Liabilities and stockholders' equity | ||||||
Current liabilities | ||||||
Accounts payable | $ |
21,004 |
$ |
23,459 |
||
Accrued payroll |
|
27,720 |
|
20,255 |
||
Accrued expenses |
|
38,820 |
|
38,654 |
||
Government stimulus advance |
|
4,173 |
|
20,368 |
||
Accrued workers compensation |
|
12,640 |
|
14,380 |
||
Current portion of long-term debt |
|
- |
|
972 |
||
Total current liabilities |
|
104,357 |
|
118,088 |
||
Long-term debt, less current portion, net of debt issuance costs |
|
256,127 |
|
193,839 |
||
Long-term operating lease liabilities, less current portion |
|
39,049 |
|
35,623 |
||
Other long-term liabilities |
|
1,900 |
|
117 |
||
Total long-term liabilities |
|
297,076 |
|
229,579 |
||
Total liabilities |
|
401,433 |
|
347,667 |
||
Total stockholders' equity |
|
585,778 |
|
529,910 |
||
Total liabilities and stockholders' equity | $ |
987,211 |
$ |
877,577 |
||
Addus HomeCare CORPORATION AND SUBSIDIARIES | ||||||
Net Service Revenue by Segment | ||||||
(Amounts in thousands) | ||||||
(Unaudited) | ||||||
For the Three Months Ended March 31, |
||||||
2022 |
2021 |
|||||
Net Service Revenues by Segment | ||||||
Personal Care | $ |
169,632 |
$ |
164,868 |
||
Hospice |
|
47,727 |
|
36,094 |
||
Home Health |
|
9,275 |
|
4,340 |
||
Total Revenue | $ |
226,634 |
$ |
205,302 |
||
Addus HomeCare CORPORATION AND SUBSIDIARIES | ||||||||||
Key Statistical and Financial Data (Unautited) | ||||||||||
For the Three Months Ended March 31, |
||||||||||
2022 |
2021 |
|||||||||
Personal Care | ||||||||||
States served at period end |
|
21 |
|
|
21 |
|
||||
Locations served at period end |
|
162 |
|
|
164 |
|
||||
Average billable census total (1) |
|
36,582 |
|
|
38,327 |
|
||||
Billable hours (in thousands) |
|
7,101 |
|
|
7,567 |
|
||||
Average billable hours per census per month |
|
64.4 |
|
|
65.2 |
|
||||
Billable hours per business day |
|
110,951 |
|
|
118,237 |
|
||||
Revenues per billable hour | $ |
23.64 |
|
$ |
21.75 |
|
||||
Organic growth | ||||||||||
- Revenue (2) |
|
0.9 |
|
% |
|
2.4 |
|
% |
||
Hospice | ||||||||||
Locations served at period end |
|
33 |
|
|
34 |
|
||||
Admissions |
|
3,315 |
|
|
2,394 |
|
||||
Average daily census |
|
3,320 |
|
|
2,400 |
|
||||
Average discharge length of stay |
|
84.1 |
|
|
101.3 |
|
||||
Patient days |
|
275,488 |
|
|
216,007 |
|
||||
Revenue per patient day | $ |
173.24 |
|
$ |
167.09 |
|
||||
Organic growth | ||||||||||
- Revenue |
|
4.4 |
|
% |
|
(8.4 |
) |
% |
||
- Average daily census |
|
7.0 |
|
% |
|
(20.2 |
) |
% |
||
Home Health | ||||||||||
Locations served at period end |
|
12 |
|
|
10 |
|
||||
New Admissions |
|
3,336 |
|
|
1,168 |
|
||||
Recertifications |
|
1,316 |
|
|
657 |
|
||||
Total Volume |
|
4,652 |
|
|
1,825 |
|
||||
Visits |
|
65,213 |
|
|
27,665 |
|
||||
Organic growth | ||||||||||
- Revenue |
|
(0.5 |
) |
% |
|
0.0 |
|
% |
||
- Total admissions |
|
2.4 |
|
% |
|
14.3 |
|
% |
||
Percentage of Revenues by Payor: | ||||||||||
Personal Care | ||||||||||
State, local and other governmental programs |
|
49.5 |
|
% |
|
49.0 |
|
% |
||
Managed care organizations |
|
45.6 |
|
|
45.8 |
|
||||
Private duty |
|
2.7 |
|
|
3.0 |
|
||||
Commercial |
|
1.2 |
|
|
1.4 |
|
||||
Other |
|
1.0 |
|
% |
|
0.8 |
|
% |
||
Hospice | ||||||||||
Medicare |
|
91.1 |
|
% |
|
94.2 |
|
% |
||
Commercial |
|
4.7 |
|
|
1.5 |
|
||||
Managed care organizations |
|
3.6 |
|
|
4.1 |
|
||||
Other |
|
0.6 |
|
% |
|
0.2 |
|
% |
||
Home Health | ||||||||||
Medicare |
|
73.4 |
|
% |
|
80.7 |
|
% |
||
Managed care organizations |
|
20.5 |
|
|
18.4 |
|
||||
Other |
|
6.1 |
|
% |
|
0.9 |
|
% |
(1) The average billable census in acquisitions of 1,593 for the three ended March 31, 2021, was reclassified to average billable census - same stores for comparability purposes. Exited sites would have reduced same store census for the three months ended March 31, 2021 by 43. | ||||
(2) Management has suspended materially all of its new patient admissions under the New York consumer self-directed program and therefore excludes associated revenues from the calculation. American Rescue Plan Act of 2021 ("ARPA") funds received have also been excluded from the calculation. |
Addus HomeCare CORPORATION AND SUBSIDIARIES | ||||||||
Reconciliation of Non-GAAP Financial Measures | ||||||||
(Amounts in thousands, except per share data) | ||||||||
(Unaudited) (1) | ||||||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Reconciliation of Adjusted EBITDA to Net Income: (2) | ||||||||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
Interest expense, net |
|
1,762 |
|
|
1,194 |
|
||
Income tax expense |
|
3,281 |
|
|
2,082 |
|
||
Depreciation and amortization |
|
3,521 |
|
|
3,601 |
|
||
COVID-19 expense, net |
|
- |
|
|
(591 |
) |
||
Acquisition and de novo expenses |
|
2,793 |
|
|
1,475 |
|
||
Stock-based compensation expense |
|
2,485 |
|
|
2,239 |
|
||
Restructuring and other non-recurring costs |
|
97 |
|
|
402 |
|
||
Adjusted EBITDA | $ |
22,409 |
|
$ |
19,296 |
|
||
Reconciliation of Adjusted Net Income to Net Income: (3) | ||||||||
Net income | $ |
8,470 |
|
$ |
8,894 |
|
||
COVID-19 expense, net of tax |
|
- |
|
|
(479 |
) |
||
Acquisition and de novo expenses, net of tax |
|
2,013 |
|
|
1,352 |
|
||
Stock-based compensation expense, net of tax |
|
1,791 |
|
|
1,814 |
|
||
Restructuring and other non-recurring costs, net of tax |
|
70 |
|
|
326 |
|
||
Adjusted Net Income |
|
12,344 |
|
|
11,907 |
|
||
Reconciliation of Diluted Earnings per Share to Adjusted Diluted Earnings per Share: (4) | ||||||||
Diluted earnings per share | $ |
0.53 |
|
$ |
0.55 |
|
||
COVID-19 expense, net per diluted share |
|
- |
|
|
(0.03 |
) |
||
Acquisition and de novo expenses, per diluted share |
|
0.13 |
|
|
0.08 |
|
||
Stock-based compensation expense per diluted share |
|
0.11 |
|
|
0.12 |
|
||
Restructuring and other non-recurring costs per diluted share |
|
- |
|
|
0.02 |
|
||
Adjusted net income per diluted share | $ |
0.77 |
|
$ |
0.74 |
|
||
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5) | ||||||||
Net service revenues | $ |
226,634 |
|
$ |
205,302 |
|
||
Revenue associated with the closure of certain sites |
|
(0 |
) |
|
(668 |
) |
||
Adjusted net service revenues | $ |
226,634 |
|
$ |
204,634 |
|
||
(1) The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. | ||||
(2) We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(3) We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(4) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure expense and other costs, loss on the sale of assets, and retroactive rate increases from Illinois. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. | ||||
(5) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. |